School personnel information

写真b

Nakata Jun


Keyword

AML, WT1

URL

http://sahswww.med.osaka-u.ac.jp/~hmtonc/index.html

Organization 【 display / non-display

  • 2014.04.01 - 2018.05.31, Graduate School of Medicine, Assistant Professor

  • 2018.06.01 - , Division of Health Sciences, Graduate School of Medicine, Assistant Professor

 

Academic Papers 【 display / non-display

  • What should we tackle next in acute myeloid leukemia? Wilms tumor gene 1 vaccine therapy would be a promising and versatile strategy for acute myeloid leukemia, Nakata J, Oji Y, Oka Y, Sugiyama H, Expert Review of Hematology,12(4) 211-213, 2019.04, Papers

  • A phase I clinical study of a cocktail vaccine of Wilms' tumor 1 (WT1) HLA class I and II peptides for recurrent malignant glioma, Tsuboi A. , et al., Cancer Immunology, Immunotherapy,68(2) 331-340, 2019.02, Papers

  • Extremely strong infiltration of WT1-specific CTLs into mouse tumor by the combination vaccine with WT1-specific CTL and helper peptide., Nakata J. et al, Oncotarget,9(89) 36029-36038, 2018.11, Papers

  • WT1 peptide-based immunotherapy for advanced thymic epithelial malignancies. , Oji Y, Inoue M, Takeda Y, Hosen N, Shintani Y, Kawakami M, Harada T, Murakami Y, Iwai M, Fukuda M, Nishida S, Nakata J, Nakae Y, Takashima S, Shirakata T, Nakajima H, Hasegawa K, Kida H, Kijima T, Morimoto S, Fujiki F, Tsuboi A, Morii E, Morita S, Sakamoto J, Kumanogoh A, Oka Y, Okumura M, Sugiyama H, International Journal of Cancer,142(11) 2375-2382, 2018.06, Papers

  • Association of WT1 IgG antibody against WT1 peptide with prolonged survival in glioblastoma multiforme patients vaccinated with WT1 peptide , Oji Y. et al, International Journal of Cancer,142(11) 2375-2382, 2018.06, Papers

display all >>